PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 275 of 640

Advanced search
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT07716579: Assessment of Endocrine and Metabolic Late Effects After Childhood Brain Tumor Treatment

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT07609719: A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT07593092: Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT07450105: Intensive Dialectical Behavior Therapy for Self-Harm and Suicidal Behavior in Youth: A Pilot Study

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT07393750: High-power Laser Versus Pulsed Electromagnetic Therapy in Lumbar Radiculopathy.

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT07288567: A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT07265258: A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT07227077: Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT07147231: Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT06968845: A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT06956001: Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT06934252: Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT06614855: A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT06609265: Extracorporeal Shockwave Therapy (ESWT) for the Management of Stress Fractures and High-grade Bone Stress Injuries (BSIs)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT06428058: Evaluating the Effects of Reproductive Health Training on Provider Behavior

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT06190158: Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease

Study type: INTERVENTIONAL. Phase: EARLY_PHASE1.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT06079879: A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT05873699: Study Using Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopic Imaging in Patients With Pancreatic Cysts Undergoing Surgical Resection

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT05797519: Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT05688982: MOLAR: Mapping Oral Health and Local Area Resources

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT05350475: Protons vs. Photons for High-risk Prostate Cancer

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT04802395: Real World Evidence Clinical Utility Study of KidneyIntelX

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT04664192: Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT04499079: Alliances to Disseminate Addiction Prevention and Treatment (ADAPT)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT04170153: Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT04014348: Geospatial Analysis of Neighborhood Environmental Stress in Relation to Biological Markers of Cardiovascular Health and Health Behaviors in Women

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT03535376: Bariatric Surgery and Pharmacokinetics of Valsartan

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT03519893: Bariatric Surgery and Pharmacokinetics of Losartan

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT03409432: Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT03181867: 18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT01784068: Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT01267955: Vismodegib in Treating Patients With Advanced Chondrosarcomas

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
馃嚭馃嚫Researchclinicaltrials.govTier 1 路 Trial registry

NCT00033137: Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
馃實discoverynews.google.comTier 3 路 Aggregated media

Oncolytics Biotech (NASDAQ:ONCY) Announces Quarterly Earnings Results, Misses Estimates By $0.03 EPS

MarketBeatOriginal source
馃實discoverynews.google.comTier 3 路 Aggregated media

Fortress Biotech Q2 Earnings Call Highlights

Yahoo FinanceOriginal source
馃嚭馃嚫CDMOveranex.comTier 2 路 Direct publisher

Veranex Appoints Beth Moeller as Chief Commercial Officer

VeranexOriginal source
馃嚭馃嚢Regulatorygov.ukTier 1 路 Regulatory source

Newborn ICU admissions drop 50% in first full year of RSV maternal vaccine programme

While around 60% of women giving birth every month are vaccinated, UKHSA warns many thousands of bab...

UK Health Security AgencyOriginal source
馃嚭馃嚢Regulatorygov.ukTier 1 路 Regulatory source

British Sign Language (BSL) 5-year plan and yearly updates: Department of Health and Social Care

Information about what the Department of Health and Social Care is doing to improve the use of BSL i...

UK Department of Health and Social CareOriginal source
馃嚭馃嚢Regulatorygov.ukTier 1 路 Regulatory source

British Sign Language (BSL) 5-year plan: Department of Health and Social Care

This plan sets out how the Department of Health and Social Care plans to improve the use of BSL in i...

UK Department of Health and Social CareOriginal source
馃實discoverynews.google.comTier 3 路 Aggregated media

Inside cardiovascular biotech Kardigan鈥檚 June IPO

CFO BrewOriginal source
馃實discoverynews.google.comTier 3 路 Aggregated media

Ultragenyx Pharmaceutical (RARE) Back In Focus As UX111 Progress Tests Valuation

simplywall.stOriginal source
馃實discoverynews.google.comTier 3 路 Aggregated media

Prader-Willi experts flag safety risks linked to Neurocrine's rare disease drug

reuters.comOriginal source
馃實discoverynews.google.comTier 3 路 Aggregated media

Biotechnology vs. Pharmaceuticals: What Are the Differences?

The Motley FoolOriginal source
馃實discoverynews.google.comTier 3 路 Aggregated media

Experts Flag Potential Safety Concerns in New Prader-Willi Drug

medpagetoday.comOriginal source
馃實discoverynews.google.comTier 2 路 Trade media

Talks on launch of clinical trial of Ebola vaccine in DRC advance, WHO says

STATOriginal source
馃實discoverynews.google.comTier 3 路 Aggregated media

China鈥檚 boom in biotech brings debate to Cambridge

Cambridge DayOriginal source
馃實Industryallogene.comTier 1 路 Company source

S-3: Simplified registration form

Allogene TherapeuticsOriginal source
馃實Industryallogene.comTier 1 路 Company source

10-Q: Quarterly report which provides a continuing view of a company鈥檚 financial position

Allogene TherapeuticsOriginal source
馃實discoverynews.google.comTier 3 路 Aggregated media

Mereo BioPharma Enters Option and License Agreement with Sentynl Therapeutics | PharmExec

Pharmaceutical ExecutiveOriginal source
馃實discoverynews.google.comTier 3 路 Aggregated media

Jeremy C. Lowe Analyzes Pharmaceutical Litigation and Regulatory Developments in Pharmaceutical Executive

Spencer FaneOriginal source
馃實Industryallogene.comTier 1 路 Company source

8-K: Report of unscheduled material events or corporate event

Allogene TherapeuticsOriginal source
馃實Industryir.talphera.comTier 1 路 Company source

Talphera Announces Second Quarter 2026 Financial Results and Provides Corporate Update

TalpheraOriginal source
馃實discoverynews.google.comTier 3 路 Aggregated media

Oral Pill for Rare Lung Disease Blocks 90% of Damaging Enzyme in Phase 2, Lands $475M Deal

Tech TimesOriginal source
馃實discoverynews.google.comTier 2 路 Trade media

AI clinical monitoring agent can deliver up to 82 times the ROI in oncology: report

Fierce BiotechOriginal source
馃實discoverynews.google.comTier 3 路 Aggregated media

Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA

PR NewswireOriginal source
馃嚭馃嚫Researchnews.nm.orgTier 2 路 Direct publisher

Northwestern Medicine study reveals hidden immune environment in myasthenia gravis patients

Northwestern MedicineOriginal source
馃嚭馃嚫Industrytechcyte.comTier 1 路 Company source

Digital Pathology Adoption Is All About Workflow

TechcyteOriginal source
馃嚜馃嚭Researchcordis.europa.euTier 2 路 Direct publisher

CORDIS project: DARK-PEP: Mapping the Human Peptidome: Genetic Variability and GPCR Signaling

CORDISOriginal source
馃嚜馃嚭Researchcordis.europa.euTier 2 路 Direct publisher

CORDIS project: Improving Oral Health Among Elderly Care Home Residents Through a Preventive Intervention: A Feasibility Randomized Controlled Trial (IOH-ElderRCT)

CORDISOriginal source
馃嚜馃嚭Researchcordis.europa.euTier 2 路 Direct publisher

CORDIS project: 4D Heart-on-a-chip: Modeling circadian rhythms in the human heart to study cardiac (patho)physiology and advance therapy

CORDISOriginal source